Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polypill Prevention Trial 1
ISRCTN36672232Phase 3Completed
- Sponsor
- Queen Mary University of London
- Start
- Jan 2011
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of simvastatin, losartan, amlodipine and hydrochlorothiazide in cardiac morbidity (2 arms), sponsored by Queen Mary University of London. Primary endpoints: Serum cholesterol, Systolic blood pressure and 1 more. Started Jan 2011; status: completed.
02
Drugs
simvastatinlosartanamlodipinehydrochlorothiazide
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on ISRCTN36672232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN36672232.